| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9239211 | HPB | 2005 | 6 Pages |
Abstract
A wide variety of nonâsurgical therapies can result in clinical responses in patients with hepatocellular carcinoma. Two recent studies have suggested that transarterial chemoembolisation can, in highly selected patients with good liver function, result in an improvement in survival. No other approaches have, to date, demonstrated convincing evidence of survival advantage.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Philip J. Johnson,